MST - Medical Surgery Technologies

Company Overview

Snapshot

Founded in January 2005 by Ziv Tamir and Moti Sholev, MST - Medical Surgery Technologies operates with 1–10 employees. The company raised $25.34M across 4 funding rounds from 6 investors. MST was acquired by Asensus in September 2018.

Business overview

MST - Medical Surgery Technologies develops image-based software for robotic surgery, aiming to enhance surgical performance and workflow efficiency. Its core product, AutoLap, is a robotic, image-guided laparoscope-positioning system that utilizes MST's image-analysis software to interact with a surgeon's movements, providing real-time guidance and control. The company operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices industry and healthcare providers with solutions for surgical procedures, including general, gynecological, and urological applications.

Strategic signal

In September 2018, TransEnterix Inc. acquired the technology and intellectual property of MST Medical Surgery Technologies for over $30 million in a stock and cash deal. This acquisition signals a strategic move by TransEnterix to enhance its digital laparoscopy offerings and expand its presence in the Israeli technology market, validating MST's innovative image-guided robotic surgery solutions.

Company Intelligence Q&A

What was a significant corporate event for MST - Medical Surgery Technologies?

MST - Medical Surgery Technologies was acquired by Asensus in September 2018. The company's assets, including intellectual property, were acquired by TransEnterix Inc. for over $30 million in a stock and cash deal.

What was a key product development for MST - Medical Surgery Technologies?

In April 2017, MST Medical Surgery Technologies conducted the first-ever live laparoscopic surgery using its image-guided robotically assisted system, AutoLap. This system frees surgical assistants from camera holding and provides stable imaging for surgeons.

When did MST - Medical Surgery Technologies receive FDA clearance for its software?

In January 2016, MST-Medical Surgery Technologies Ltd. received clearance from the U.S. Food and Drug Administration (FDA) for its Follow Me™ software, an advanced function of its AutoLap® system for minimally invasive robotic surgery.

Which investors participated in MST - Medical Surgery Technologies' C Round funding?

In July 2015, MST - Medical Surgery Technologies received C Round funding from investors including Triventures and OurCrowd.

What was the strategic impact of the TransEnterix acquisition?

The acquisition of MST's technology and intellectual property by TransEnterix Inc. in September 2018 was intended to enhance TransEnterix's existing digital laparoscopy offerings and allow them to access the local technology scene in Israel.